Another study by Richmond et al. (2015), showed that combining RG7112 with an induction type regimen (vincristine, dexamethasone, and L-asparaginase) significantly enhanced objective responses and prolonged leukemia regression in vivo MLL-ALL xenografts. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.